(19)
(11) EP 4 540 251 A1

(12)

(43) Date of publication:
23.04.2025 Bulletin 2025/17

(21) Application number: 23739358.2

(22) Date of filing: 16.06.2023
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
A61P 25/00(2006.01)
A61P 3/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 3/00; A61P 25/00; C07D 487/04
(86) International application number:
PCT/IB2023/056244
(87) International publication number:
WO 2023/242809 (21.12.2023 Gazette 2023/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 17.06.2022 HU 2200221

(71) Applicant: Richter Gedeon Nyrt.
1103 Budapest (HU)

(72) Inventors:
  • JANKE, Dénes
    1163 Budapest (HU)
  • HOFFMANNÉ SZALAY, Zsófia
    1183 Budapest (HU)
  • DEMETER, Ádám
    1163 Budapest (HU)
  • BEKE, Gyula
    2092 Budakeszi (HU)

(74) Representative: Kutzenberger Wolff & Partner 
Waidmarkt 11
50676 Köln
50676 Köln (DE)

   


(54) CRYSTALLINE FORMS OF 4-[(5-CHLOROPYRIDIN-2-YL)METHOXY]-1-[3-(PROPAN-2-YL)-1H,2H,3H,4H,5H-[1,4]DIAZEPINO[1,7-A]INDOL-9-YL]-1,2-DIHYDROPYRIDIN-2-ONE AND SALTS THEREOF, METHOD OF PREPARATION, AND USES THEREOF